臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"lin c c"

Return to Browse by Author
Sorting by Title	Sort by Date

Showing items 1291-1315 of 2549 (102 Page(s) Totally)
<< < 47 48 49 50 51 52 53 54 55 56 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2020-05-26T09:27:19Z	Epidermal growth factor receptor tyrosine kinase inhibitors in elderly or poor performance status patients with advanced non-small cell lung cancer	Lin C.-C;Chih-Hsin Yang; Lin C.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:18Z	Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors	Lin C.-C;Hsu H.-H;Sun C.-T;Shih J.-Y;Lin Z.-Z;Yu C.-J;Chen G.G;Hsin M.K.Y;Lam K.C;Leung L;Chih-Hsin Yang;Mok T.; Lin C.-C; Hsu H.-H; Sun C.-T; Shih J.-Y; Lin Z.-Z; Yu C.-J; Chen G.G; Hsin M.K.Y; Lam K.C; Leung L; CHIH-HSIN YANG; Mok T.
臺大學術典藏	2020-05-26T09:27:17Z	Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancer.	Shao Y.Y;Lin C.C;Chih-Hsin Yang; Shao Y.Y; Lin C.C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:14Z	Optimal management of patients with non-small cell lung cancer and epidermal growth factor receptor mutations	Lin C.-C;Chih-Hsin Yang; Lin C.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:10Z	Polo-like kinase 1 inhibitors and their potential role in anticancer therapy, with a focus on NSCLC	Medema R.H;Lin C.-C;Chih-Hsin Yang; Medema R.H; Lin C.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:03Z	First-line management of EGFR-mutated advanced lung adenocarcinoma: Recent developments	Liao B.-C;Lin C.-C;Chih-Hsin Yang; Liao B.-C; Lin C.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:02Z	EGFR inhibitors as the first-line systemic treatment for advanced non-small-cell lung cancer	Kao H.-F;Lin C.-C;Chih-Hsin Yang; Kao H.-F; Lin C.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:00Z	Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer	Lee J.-H; Lin Y.-L; Hsu W.-H; Chen H.-Y; Chang Y.-C; Yu C.-J; Shih J.-Y; Lin C.-C; Chen K.-Y; Ho C.-C; Laio W.-Y; Yang P.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:00Z	A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors	Ghamande S; Lin C.-C; Cho D.C; Shapiro G.I; Kwak E.L; Goel S.; Chuadhary I; Ghalib M.H; Cheng A.-L; CHIH-HSIN YANG; Coleman T; Silverman M.H; Tseng Y; Kuo M.-W; Mach W.B; Hsu S.-C
臺大學術典藏	2020-05-26T09:26:59Z	First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: A randomised, phase 3 trial	CHIH-HSIN YANG; Kang J.H; Mok T; Ahn M.-J; Srimuninnimit V; Lin C.-C; Kim D.-W; Tsai C.-M; Barraclough H; Altug S; Orlando M; Park K.
臺大學術典藏	2020-05-26T09:26:57Z	A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies	Lin C.-C;Su W.-C;Yen C.-J;Hsu C.-H;Su W.-P;Yeh K.-H;Lu Y.-S;Cheng A.-L;Huang D.C.-L;Fritsch H;Voss F;Taube T;Chih-Hsin Yang; Lin C.-C; Su W.-C; Yen C.-J; Hsu C.-H; Su W.-P; Yeh K.-H; Lu Y.-S; Cheng A.-L; Huang D.C.-L; Fritsch H; Voss F; Taube T; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:55Z	Second and third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer	Chih-Hsin Yang;Lin C.-C;Liao B.-C; Liao B.-C; Lin C.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:55Z	Treating patients with ALK-positive non-small cell lung cancer: Latest evidence and management strategy	Chih-Hsin Yang;Shih J.Y;Lin C.C;Liao B.C; Liao B.C; Lin C.C; Shih J.Y; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:52Z	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis	Chih-Hsin Yang;Yu C.-J;Shih J.-Y;Ho C.-C;Chang C.-H;Chen Y.-F;Lin C.-C;Lee J.-H;Liao B.-C; Liao B.-C; Lee J.-H; Lin C.-C; Chen Y.-F; Chang C.-H; Ho C.-C; Shih J.-Y; Yu C.-J; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:48Z	Gefitinib maintenance therapy versus gefitinib monotherapy in east asian never-smoker patients with locally advanced or metastatic nonsquamous non-small cell lung cancer: Final overall survival results from a randomized phase 3 study	Park K.;Wang X;Puri T;Orlando M;Mok T;Tsai C.-M;Kim S.-W;Lin C.-C;Ahn M.-J;Srimuninnimit V;Chih-Hsin Yang; CHIH-HSIN YANG; Srimuninnimit V; Ahn M.-J; Lin C.-C; Kim S.-W; Tsai C.-M; Mok T; Orlando M; Puri T; Wang X; Park K.
臺大學術典藏	2020-05-26T09:26:47Z	151P: Outcomes of research biopsies in clinical trials of EGFR mutation-positive NSCLC patients pretreated with EGFR-TKIs	Chih-Hsin Yang;Yu C.-J;Chang Y.-C;Shih J.-Y;Ho C.-C;Lee Y.-F;Lin S.-Y;Lin C.-C;Bai Y.-Y;Liao B.-C; Liao B.-C; Bai Y.-Y; Lin C.-C; Lin S.-Y; Lee Y.-F; Ho C.-C; Shih J.-Y; Chang Y.-C; Yu C.-J; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:45Z	Safety of gefitinib in non-small cell lung cancer treatment	Chih-Hsin Yang;Lin C.-C;Lee J.-H;Hsiue E.H.-C; Hsiue E.H.-C; Lee J.-H; Lin C.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:43Z	Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitors	Chih-Hsin Yang;Lee J.-H;Lin C.-C;Liao B.-C; Liao B.-C; Lin C.-C; Lee J.-H; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:43Z	Profile of the therascreen® EGFR RGQ PCR kit as a companion diagnostic for gefitinib in non-small cell lung cancer	Chih-Hsin Yang;Lin C.-C;Lee J.-H;Hsiue E.H.-C; Hsiue E.H.-C; Lee J.-H; Lin C.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:38Z	Osimertinib in pretreated T790M-positive advanced non-small-cell lung cancer: AURA study phase II extension component	J?nne P.A.;Ghiorghiu S;Cantarini M;Mann H;Lin C.-C;Hirashima T;Gold K;Novello S;Yoh K;Haggstrom D;Blackhall F;Felip E;Planchard D;Kim J.-H;Kim S.-W;Su W.-C;Sequist L.V;Ramalingam S.S;Kim D.-W;Ahn M.-J;Chih-Hsin Yang; CHIH-HSIN YANG; Ahn M.-J; Kim D.-W; Ramalingam S.S; Sequist L.V; Su W.-C; Kim S.-W; Kim J.-H; Planchard D; Felip E; Blackhall F; Haggstrom D; Yoh K; Novello S; Gold K; Hirashima T; Lin C.-C; Mann H; Cantarini M; Ghiorghiu S; Jänne P.A.
臺大學術典藏	2020-05-26T09:26:36Z	Optimal management of EGFR-mutant non-small cell lung cancer with disease progression on first-line tyrosine kinase inhibitor therapy	Chih-Hsin Yang;Lee J.-H;Lin C.-C;Liao B.-C; Liao B.-C; Lin C.-C; Lee J.-H; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:36Z	Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib	Yu C.-J.;Chih-Hsin Yang;Lin C.-C;Lin Z.-Z;Chen J.-S;Shih J.-Y;Chen K.-Y;Ho C.-C;Liao W.-Y;Yao Z.-H; Yao Z.-H; Liao W.-Y; Ho C.-C; Chen K.-Y; Shih J.-Y; Chen J.-S; Lin Z.-Z; Lin C.-C; CHIH-HSIN YANG; Yu C.-J.
臺大學術典藏	2020-05-26T09:26:34Z	Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan	Yu C.-J.;Chih-Hsin Yang;Shih J.-Y;Lin C.-C;Lee J.-H;Chang Y.-L;Su K.-Y;Hsu W.-H;Hsu C.-L;Tsai T.-H;Chen K.-Y;Liao W.-Y;Ho C.-C;Liao B.-C;Yang C.-Y;Lin S.-Y; Lin S.-Y; Yang C.-Y; Liao B.-C; Ho C.-C; Liao W.-Y; Chen K.-Y; Tsai T.-H; Hsu C.-L; Hsu W.-H; Su K.-Y; Chang Y.-L; Lee J.-H; Lin C.-C; Shih J.-Y; CHIH-HSIN YANG; Yu C.-J.
臺大學術典藏	2020-05-26T09:26:31Z	Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study	Chih-Hsin Yang;Thress K.S;Huang D.D.-R;Bai Y.-Y;Chang Y.-L;Hsieh M.-S;Su K.-Y;Tsai T.-H;Lee J.-H;Liao W.-Y;Ho C.-C;Yu C.-J;Shih J.-Y;Lin C.-C; Lin C.-C; Shih J.-Y; Yu C.-J; Ho C.-C; Liao W.-Y; Lee J.-H; Tsai T.-H; Su K.-Y; Hsieh M.-S; Chang Y.-L; Bai Y.-Y; Huang D.D.-R; Thress K.S; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:29Z	Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors	Yang P.-C.;Chih-Hsin Chih-Hsin Yang;Yu C.-J;Chang Y.-C;Shih J.-Y;Ho C.-C;Lee Y.-F;Lin S.-Y;Lin C.-C;Lee J.-H;Bai Y.-Y;Liao B.-C; Liao B.-C; Bai Y.-Y; Lee J.-H; Lin C.-C; Lin S.-Y; Lee Y.-F; Ho C.-C; Shih J.-Y; Chang Y.-C; Yu C.-J; Chih-Hsin CHIH-HSIN YANG; Yang P.-C.

Showing items 1291-1315 of 2549 (102 Page(s) Totally)
<< < 47 48 49 50 51 52 53 54 55 56 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| Total items :0
	Visitors : 52586842 Online Users : 711 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library